Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 2, 2008, Pages 128-147

  Kockskämper, Jens ^a   Zima, Aleksey V ^b   Roderick, H Llewelyn ^c,d   Pieske, Burkert ^a   Blatter, Lothar A ^b   Bootman, Martin D ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b RUSH MEDICAL COLLEGE   (United States)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Arrhythmias; Calcium; Cardiac myocyte; Hypertrophy; Inositol 1,4,5 trisphosphate; Inotropy; Nucleus

Indexed keywords

CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHOLIPASE C; RYANODINE RECEPTOR;

CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART DEVELOPMENT; HEART EXCITATION; HEART FAILURE; HEART MUSCLE CELL; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 48849112871     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.05.014     Document Type: Review

References (205)

1. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306 (1983) 67-69
2. 2+: molecular determinants and functional consequences. Physiol Rev 86 (2006) 369-408
3. Vazquez G., Wedel B.J., Bird G.S., Joseph S.K., and Putney J.W. An inositol 1,4,5-trisphosphate receptor-dependent cation entry pathway in DT40 B lymphocytes. Embo J 21 (2002) 4531-4538
4. Woodcock E.A., Lambert K.A., Phan T., and Jacobsen A.N. Inositol phosphate metabolism during myocardial ischemia. J Mol Cell Cardiol 29 (1997) 449-460
5. 2 by cardioactive hormones and other physiologically relevant interventions. Am J Physiol Cell Physiol 283 (2002) C223-C234
6. 2 with ion channels and transporters. Sci STKE 2001 (2001) RE19
7. 2-binding proteins involved in signaling by tyrosine kinase. J Biol Chem 269 (1994) 1518-1522
8. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70 (2001) 281-312
9. Cockcroft S. The latest phospholipase C, PLCeta, is implicated in neuronal function. Trends Biochem Sci 31 (2006) 4-7
10. Leung E., Johnston C.I., and Woodcock E.A. Stimulation of phosphatidylinositol metabolism in atrial and ventricular myocytes. Life Sci 39 (1986) 2215-2220
11. Remus T.P., Zima A.V., Bossuyt J., Bare D.J., Martin J.L., Blatter L.A., et al. Biosensors to measure inositol 1,4,5-trisphosphate concentration in living cells with spatiotemporal resolution. J Biol Chem 281 (2006) 608-616
12. 3 transients in the cardiac myocyte. Biophys J 93 (2007) 3421-3433
13. Nasuhoglu C., Feng S., Mao J., Yamamoto M., Yin H.L., Earnest S., et al. Nonradioactive analysis of phosphatidylinositides and other anionic phospholipids by anion-exchange high-performance liquid chromatography with suppressed conductivity detection. Anal Biochem 301 (2002) 243-254
14. Woodcock E.A., and Lambert K.A. Acute effects of cell isolation on InsP profiles in adult rat cardiomyocytes. J Mol Cell Cardiol 29 (1997) 3275-3283
15. Yamada J., Ohkusa T., Nao T., Ueyama T., Yano M., Kobayashi S., et al. Up-regulation of inositol 1,4,5 trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation. J Am Coll Cardiol 37 (2001) 1111-1119
16. Gorza L., Schiaffino S., and Volpe P. Inositol 1,4,5-trisphosphate receptor in heart: evidence for its concentration in Purkinje myocytes of the conduction system. J Cell Biol 121 (1993) 345-353
17. 3)-receptor type 2-deficient mice. Circ Res 96 (2005) 1274-1281
18. Bare D.J., Kettlun C.S., Liang M., Bers D.M., and Mignery G.A. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J Biol Chem 280 (2005) 15912-15920
19. Go L.O., Moschella M.C., Watras J., Handa K.K., Fyfe B.S., and Marks A.R. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 95 (1995) 888-894
20. Bultynck G., Sienaert I., Parys J.B., Callewaert G., De Smedt H., Boens N., et al. Pharmacology of inositol trisphosphate receptors. Pflugers Arch 445 (2003) 629-642
21. Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium 38 (2005) 261-272
22. 2+ channel: from discovery to new signaling concepts. J Neurochem 102 (2007) 1426-1446
23. 2+ release channels. Physiol Rev 87 (2007) 593-658
24. 3 receptor: regulation by calcium and accessory factors. Biochem Soc Trans 31 (2003) 950-953
25. 2+ release and apoptosis. Proc Natl Acad Sci U S A (2008)
26. Tang T.S., Tu H., Wang Z., and Bezprozvanny I. Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha. J Neurosci 23 (2003) 403-415
27. Gomes D.A., Leite M.F., Bennett A.M., and Nathanson M.H. Calcium signaling in the nucleus. Can J Physiol Pharmacol 84 (2006) 325-332
28. Boivin B., Chevalier D., Villeneuve L.R., Rousseau E., and Allen B.G. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem 278 (2003) 29153-29163
29. Allbritton N.L., Meyer T., and Stryer L. Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science 258 (1992) 1812-1815
30. York J.D. Regulation of nuclear processes by inositol polyphosphates. Biochim Biophys Acta 1761 (2006) 552-559
31. Scholz J., Troll U., Sandig P., Schmitz W., Scholz H., and Schulte Am Esch J. Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart. Mol Pharmacol 42 (1992) 134-140
32. Kijima Y., and Fleischer S. Two types of inositol trisphosphate binding in cardiac microsomes. Biochem Biophys Res Commun 189 (1992) 728-735
33. Rowley K.G., Gundlach A.L., Cincotta M., and Louis W.J. Inositol hexakisphosphate binding sites in rat heart and brain. Br J Pharmacol 118 (1996) 1615-1620
34. Dean N.M., and Beaven M.A. Methods for the analysis of inositol phosphates. Anal Biochem 183 (1989) 199-209
35. 3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay. Biochem J 265 (1990) 421-427
36. Woodcock E.A. Analysis of inositol phosphates in heart tissue using anion-exchange high-performance liquid chromatography. Mol Cell Biochem 172 (1997) 121-127
37. Nahorski S.R., Young K.W., John Challiss R.A., and Nash M.S. Visualizing phosphoinositide signalling in single neurons gets a green light. Trends Neurosci 26 (2003) 444-452
38. Tanimura A., Nezu A., Morita T., Turner R.J., and Tojyo Y. Fluorescent biosensor for quantitative real-time measurements of inositol 1,4,5-trisphosphate in single living cells. J Biol Chem 279 (2004) 38095-38098
39. Sugimoto K., Nishida M., Otsuka M., Makino K., Ohkubo K., Mori Y., et al. Novel real-time sensors to quantitatively assess in vivo inositol 1,4,5-trisphosphate production in intact cells. Chem Biol 11 (2004) 475-485
40. 2+, diacylglycerol, and protein kinase C signaling using fluorescent biosensors. J Biol Chem 280 (2005) 21837-21846
41. 2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 294 (2008) H596-H604
42. 2+ release. Faseb J 16 (2002) 1145-1150
43. 2+ signalling: problems and pitfalls. Trends Pharmacol Sci 19 (1998) 370-375
44. 2+ release sites in non-excitable cells. Curr Biol 10 (2000) 8-15
45. 2+ spike frequency can optimize gene expression. Nature 392 (1998) 936-941
46. 3 in living cells. Chembiochem 7 (2006) 174-180
47. 2+ from a non-mitochondrial store site in peritoneal macrophages treated with saponin by inositol 1,4,5-trisphosphate. Biochem J 223 (1984) 229-236
48. Nosek T.M., Williams M.F., Zeigler S.T., and Godt R.E. Inositol trisphosphate enhances calcium release in skinned cardiac and skeletal muscle. Am J Physiol 250 (1986) C807-C811
49. 3. Am J Physiol 258 (1990) H610-H615
50. 2+ in permeabilized chick atria. Am J Physiol 258 (1990) H1745-H1752
51. Fabiato A. Two kinds of calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cardiac cells. Adv Exp Med Biol 311 (1992) 245-262
52. Bers D.M., and Stiffel V.M. Ratio of ryanodine to dihydropyridine receptors in cardiac and skeletal muscle and implications for E-C coupling. Am J Physiol 264 (1993) C1587-C1593
53. Bers D.M. Excitation-contraction coupling and cardiac contractile force. 2nd ed. (2001), Kluwer Academic Publishers, Dordrecht
54. Moschella M.C., and Marks A.R. Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes. J Cell Biol 120 (1993) 1137-1146
55. 2+ accumulation in nonfailing and failing human myocardium. Circulation 92 (1995) 2504-2510
56. Jeyakumar L.H., Ballester L., Cheng D.S., McIntyre J.O., Chang P., Olivey H.E., et al. FKBP binding characteristics of cardiac microsomes from diverse vertebrates. Biochem Biophys Res Commun 281 (2001) 979-986
57. Perez P.J., Ramos-Franco J., Fill M., and Mignery G.A. Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J Biol Chem 272 (1997) 23961-23969
58. 3 receptors that may modulate excitation-contraction coupling in the heart. Curr Biol 10 (2000) 939-942
59. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
60. 2+ is loading-dependent. J Biol Chem 269 (1994) 7238-7242
61. 2+. Biochem J 306 (1995) 445-451
62. Gilbert J.C., Shirayama T., and Pappano A.J. Inositol trisphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ Res 69 (1991) 1632-1639
63. 2+ signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol 541 (2002) 395-409
64. Ter Keurs H.E., and Boyden P.A. Calcium and arrhythmogenesis. Physiol Rev 87 (2007) 457-506
65. Eisner D.A., Trafford A.W., Diaz M.E., Overend C.L., and O'Neill S.C. The control of Ca release from the cardiac sarcoplasmic reticulum: regulation versus autoregulation. Cardiovasc Res 38 (1998) 589-604
66. Eisner D.A., Choi H.S., Diaz M.E., O'Neill S.C., and Trafford A.W. Integrative analysis of calcium cycling in cardiac muscle. Circ Res 87 (2000) 1087-1094
67. Trafford A.W., Diaz M.E., and Eisner D.A. Stimulation of Ca-induced Ca release only transiently increases the systolic Ca transient: measurements of Ca fluxes and sarcoplasmic reticulum Ca. Cardiovasc Res 37 (1998) 710-717
68. Bassani J.W., Bassani R.A., and Bers D.M. Twitch-dependent SR Ca accumulation and release in rabbit ventricular myocytes. Am J Physiol 265 (1993) C533-C540
69. 2+ sensing sites. Biophys J 75 (1998) 2801-2810
70. 2+ signalling in cat atrial excitation-contraction coupling and arrhythmias. J Physiol 555 (2004) 607-615
71. Bootman M.D., Harzheim D., Smyrnias I., Conway S.J., and Roderick H.L. Temporal changes in atrial EC-coupling during prolonged stimulation with endothelin-1. Cell Calcium 42 (2007) 489-501
72. 2+ stores. J Cell Sci 121 (2008) 186-195
73. Berridge M.J. Elementary and global aspects of calcium signalling. J Exp Biol 200 (1997) 315-319
74. 2+ signals. J Cell Sci 114 (2001) 2213-2222
75. Cheng H., Lederer W.J., and Cannell M.B. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262 (1993) 740-744
76. 2+ in voltage-clamped rat heart cells: visualization with confocal microscopy. J Physiol 480 (1994) 21-29
77. Tsugorka A., Rios E., and Blatter L.A. Imaging elementary events of calcium release in skeletal muscle cells. Science 269 (1995) 1723-1726
78. Huser J., Lipsius S.L., and Blatter L.A. Calcium gradients during excitation-contraction coupling in cat atrial myocytes. J Physiol 494 (1996) 641-651
79. 2+ liberation in Xenopus oocytes: hot spots, puffs and blips. Cell Calcium 20 (1996) 105-121
80. 2+ release in vascular endothelial cells. Am J Physiol 273 (1997) C1775-C1782
81. 2+ sparks in cardiac muscle. Proc Natl Acad Sci U S A 94 (1997) 4176-4181
82. 2+ signalling system in HeLa cells. J Physiol 499 (1997) 307-314
83. Gyorke S., Lukyanenko V., and Gyorke I. Dual effects of tetracaine on spontaneous calcium release in rat ventricular myocytes. J Physiol 500 (1997) 297-309
84. Berridge M.J. Elementary and global aspects of calcium signalling. J Physiol 499 (1997) 291-306
85. Fu J.D., and Yang H.T. Developmental regulation of intracellular calcium homeostasis in early cardiac myocytes. Sheng Li Xue Bao 58 (2006) 95-103
86. 2+ signalling in cardiogenesis. Cell Calcium 38 (2005) 383-389
87. Takeshima H., Komazaki S., Hirose K., Nishi M., Noda T., and Iino M. Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. Embo J 17 (1998) 3309-3316
88. Yang H.T., Tweedie D., Wang S., Guia A., Vinogradova T., Bogdanov K., et al. The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci U S A 99 (2002) 9225-9230
89. 2+ oscillations, a potential pacemaking mechanism in early embryonic heart cells. J Gen Physiol 130 (2007) 133-144
90. 2+ handling in mouse ventricular cells from early embryo to adulthood. Life Sci 71 (2002) 1279-1292
91. Rosemblit N., Moschella M.C., Ondriasa E., Gutstein D.E., Ondrias K., and Marks A.R. Intracellular calcium release channel expression during embryogenesis. Dev Biol 206 (1999) 163-177
92. Schroder E.A., Wei Y., and Satin J. The developing cardiac myocyte: maturation of excitability and excitation-contraction coupling. Ann N Y Acad Sci 1080 (2006) 63-75
93. Sachinidis A., Fleischmann B.K., Kolossov E., Wartenberg M., Sauer H., and Hescheler J. Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res 58 (2003) 278-291
94. Banach K., Halbach M.D., Hu P., Hescheler J., and Egert U. Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. Am J Physiol Heart Circ Physiol 284 (2003) H2114-H2123
95. Kolossov E., Fleischmann B.K., Liu Q., Bloch W., Viatchenko-Karpinski S., Manzke O., et al. Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol 143 (1998) 2045-2056
96. f current and spontaneous activity in mouse embryonic ventricular myocytes. Circ Res 88 (2001) 536-542
97. Mery A., Aimond F., Menard C., Mikoshiba K., Michalak M., and Puceat M. Initiation of embryonic cardiac pacemaker activity by inositol 1,4,5-trisphosphate-dependent calcium signaling. Mol Biol Cell 16 (2005) 2414-2423
98. 2+ oscillations drive spontaneous contractions in cardiomyocytes during early development. Proc Natl Acad Sci U S A 96 (1999) 8259-8264
99. Fu J.D., Yu H.M., Wang R., Liang J., and Yang H.T. Developmental regulation of intracellular calcium transients during cardiomyocyte differentiation of mouse embryonic stem cells. Acta Pharmacol Sin 27 (2006) 901-910
100. Sauer H., Theben T., Hescheler J., Lindner M., Brandt M.C., and Wartenberg M. Characteristics of calcium sparks in cardiomyocytes derived from embryonic stem cells. Am J Physiol Heart Circ Physiol 281 (2001) H411-H421
101. Kapur N., and Banach K. Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes. J Physiol 581 (2007) 1113-1127
102. 2+ spiking. Mol Biol Cell 11 (2000) 1845-1858
103. 2+ sparks and waves mediated by inositol 1,4,5-trisphosphate receptors in neonatal rat cardiomyocytes. Cell Calcium 43 (2008) 165-174
104. Shubeita H.E., McDonough P.M., Harris A.N., Knowlton K.U., Glembotski C.C., Brown J.H., et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 265 (1990) 20555-20562
105. Iwaki K., Sukhatme V.P., Shubeita H.E., and Chien K.R. Alpha- and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response. J Biol Chem 265 (1990) 13809-13817
106. Ibarra C., Estrada M., Carrasco L., Chiong M., Liberona J.L., Cardenas C., et al. Insulin-like growth factor-1 induces an inositol 1,4,5-trisphosphate-dependent increase in nuclear and cytosolic calcium in cultured rat cardiac myocytes. J Biol Chem 279 (2004) 7554-7565
107. 2+ signaling in developing cardiac cells. Ann N Y Acad Sci 1080 (2006) 154-164
108. 2+ regulates cardiomyocyte function. Cell Calcium (2008 Jan 15)
109. Luo D.L., Gao J., Lan X.M., Wang G., Wei S., Xiao R.P., et al. Role of inositol 1,4,5-trisphosphate receptors in alpha1-adrenergic receptor-induced cardiomyocyte hypertrophy. Acta Pharmacol Sin 27 (2006) 895-900
110. Matsumoto M., Nakagawa T., Inoue T., Nagata E., Tanaka K., Takano H., et al. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379 (1996) 168-171
111. 3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309 (2005) 2232-2234
112. Brown S.L., and Brown J.H. Muscarinic stimulation of phosphatidylinositol metabolism in atria. Mol Pharmacol 24 (1983) 351-356
113. Ransnas L., Gjorstrup P., Hjalmarson A., Sjogren C.G., and Jacobsson B. Muscarinic receptors in mammalian myocardium: effects of atrial and ventricular receptors on phosphatidylinositol metabolism and adenylate cyclase. J Mol Cell Cardiol 18 (1986) 807-814
114. Tajima T., Tsuji Y., Brown J.H., and Pappano A.J. Pertussis toxin-insensitive phosphoinositide hydrolysis, membrane depolarization, and positive inotropic effect of carbachol in chick atria. Circ Res 61 (1987) 436-445
115. Imai S., and Ohta H. Positive inotropic effects induced by carbachol in rat atria treated with islet-activating protein (IAP)-association with phosphatidylinositol breakdown. Br J Pharmacol 94 (1988) 347-354
116. 1-receptor-induced stimulation of phosphoinositide turnover. J Pharmacol Exp Ther 247 (1988) 466-472
117. Scholz J., Schaefer B., Schmitz W., Scholz H., Steinfath M., Lohse M., et al. Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart. J Pharmacol Exp Ther 245 (1988) 327-335
118. Baker K.M., and Singer H.A. Identification and characterization of guinea pig angiotensin II ventricular and atrial receptors: coupling to inositol phosphate production. Circ Res 62 (1988) 896-904
119. Baker K.M., and Aceto J.A. Characterization of avian angiotensin II cardiac receptors: coupling to mechanical activity and phosphoinositide metabolism. J Mol Cell Cardiol 21 (1989) 375-382
120. Vigne P., Lazdunski M., and Frelin C. The inotropic effect of endothelin-1 on rat atria involves hydrolysis of phosphatidylinositol. FEBS Lett 249 (1989) 143-146
121. Kohl C., Schmitz W., and Scholz H. Positive inotropic effect of carbachol and inositol phosphate levels in mammalian atria after pretreatment with pertussis toxin. J Pharmacol Exp Ther 254 (1990) 894-899
122. Zerkowski H.R., Broede A., Kunde K., Hillemann S., Schafer E., Vogelsang M., et al. Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn Schmiedebergs Arch Pharmacol 347 (1993) 347-352
123. A-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium. J Cardiovasc Pharmacol 23 (1994) 344-347
124. Laer S., Remmers F., Scholz H., Stein B., Muller F.U., and Neumann J. Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium. Br J Pharmacol 123 (1998) 1182-1188
125. 3-muscarinic receptors in the human heart. Naunyn Schmiedebergs Arch Pharmacol 368 (2003) 316-319
126. 3-induced contractions by myoplasmic calcium in permeabilized atrial muscle. Cardiovasc Res 30 (1995) 905-914
127. Mackenzie L., Roderick H.L., Berridge M.J., Conway S.J., and Bootman M.D. The spatial pattern of atrial cardiomyocyte calcium signalling modulates contraction. J Cell Sci 117 (2004) 6327-6337
128. Mackenzie L., Roderick H.L., Proven A., Conway S.J., and Bootman M.D. Inositol 1,4,5-trisphosphate receptors in the heart. Biol Res 37 (2004) 553-557
129. 2+-release channel-ryanodine receptor-in human atrial cells. J Mol Cell Cardiol 32 (2000) 2051-2063
130. + channels from human and sheep atrial cells display a specific electro-pharmacological profile. J Mol Cell Cardiol 34 (2002) 1163-1172
131. Holubarsch C., Hasenfuss G., Schmidt-Schweda S., Knorr A., Pieske B., Ruf T., et al. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. Circulation 88 (1993) 1228-1237
132. Kockskamper J., Sigirci E., Pieske B.,. Endothelin-1 elicits direct arrhythmogenic effects in rabbit and human atrial myocardium. Pflugers Arch 447 (2004) P26-P33 [Abstract]
133. Pieske B., and Kockskamper J. Alternans goes subcellular: a "disease" of the ryanodine receptor?. Circ Res 91 (2002) 553-555
134. Burrell K.M., Molenaar P., Dawson P.J., and Kaumann A.J. Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: blockade with SB 209670. J Pharmacol Exp Ther 292 (2000) 449-459
135. Kockskämper J., Sigirci E., Rübertus S.U., and Pieske B. Endothelin-1 elicits arrhythmias in human atrium via modulation of intracellular calcium release. Circulation 110 (2004) 163 [Abstract]
136. Gassanov N., Brandt M.C., Michels G., Lindner M., Er F., and Hoppe U.C. Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. Cell Calcium 39 (2006) 175-186
137. 2+ signalling in the mammalian heart. J Physiol 584 (2007) 601-611
138. 3 receptor mRNA in adult rat hearts in a glucocorticoid-dependent manner. FEBS Lett 531 (2002) 432-436
139. Mohler P.J., Yoon W., and Bennett V. Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes. J Biol Chem 279 (2004) 40185-40193
140. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116 (2006) 675-682
141. 2+ store throughout cardiac myocyte. Circ Res 99 (2006) 283-291
142. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421 (2003) 634-639
143. Proven A., Roderick H.L., Conway S.J., Berridge M.J., Horton J.K., Capper S.J., et al. Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J Cell Sci 119 (2006) 3363-3375
144. 3 generation in the mouse heart: a comparison with ischaemic preconditioning. Clin Sci (Lond) 114 (2008) 157-164
145. Woodcock E.A., Arthur J.F., and Matkovich S.J. Inositol 1,4,5-trisphosphate and reperfusion arrhythmias. Clin Exp Pharmacol Physiol 27 (2000) 734-737
146. Felzen B., Shilkrut M., Less H., Sarapov I., Maor G., Coleman R., et al. Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice: a major role for inositol 1,4,5-trisphosphate. Circ Res 82 (1998) 438-450
147. 3 cascade: a potential target for treating heart failure and arrhythmias. Ann N Y Acad Sci 1015 (2004) 338-350
148. 3Rs) in myocardial nuclei involved in pressure overload-induced hypertrophy of rat heart. Sheng Li Xue Bao 53 (2001) 281-285
149. 2+/calmodulin-dependent protein kinase II{delta} and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure. Circ Res 102 (2008) 695-702
150. Sugden P.H., and Clerk A. Endothelin signalling in the cardiac myocyte and its pathophysiological relevance. Curr Vasc Pharmacol 3 (2005) 343-351
151. Beghetti M., Black S.M., and Fineman J.R. Endothelin-1 in congenital heart disease. Pediatr Res 57 (2005) 16R-20R
152. Singal T., Dhalla N.S., and Tappia P.S. Phospholipase C may be involved in norepinephrine-induced cardiac hypertrophy. Biochem Biophys Res Commun 320 (2004) 1015-1019
153. q interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280 (1998) 574-577
154. Ito H., Hirata Y., Hiroe M., Tsujino M., Adachi S., Takamoto T., et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69 (1991) 209-215
155. Roderick H.L., Higazi D.R., Smyrnias I., Fearnley C., Harzheim D., and Bootman M.D. Calcium in the heart: when it's good, it's very very good, but when it's bad, it's horrid. Biochem Soc Trans 35 (2007) 957-961
156. 2+ in the heart: contraction versus intracellular signaling. J Clin Invest 116 (2006) 623-626
157. Garcia K.D., Shah T., and Garcia J. Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice. Am J Physiol Cell Physiol 287 (2004) C1048-C1057
158. Barac Y.D., Zeevi-Levin N., Yaniv G., Reiter I., Milman F., Shilkrut M., et al. The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc Res 68 (2005) 75-86
159. 2+ release from cardiac sarcoplasmic reticulum. Pflugers Arch 418 (1991) 1-6
160. Maltsev V.A., and Lakatta E.G. Normal heart rhythm is initiated and regulated by an intracellular calcium clock within pacemaker cells. Heart Lung Circ 16 (2007) 335-348
161. Mori T., and Hashimoto A. Direct positive chronotropic action by angiotensin II in the isolated mouse atrium. Life Sci 79 (2006) 637-640
162. A endothelin receptor-mediated negative chronotropic response in right atria-species difference and intracellular mechanisms. Br J Pharmacol 125 (1998) 787-797
163. Bramich N.J., Cousins H.M., Edwards F.R., and Hirst G.D. Parallel metabotropic pathways in the heart of the toad, Bufo marinus. Am J Physiol Heart Circ Physiol 281 (2001) H1771-H1777
164. 2+ activation. Circ Res 97 (2005) 35-43
165. Viamonte V.M., Steinberg S.F., Chow Y.K., Legato M.J., Robinson R.B., and Rosen M.R. Phospholipase C modulates automaticity of canine cardiac Purkinje fibers. J Pharmacol Exp Ther 252 (1990) 886-893
166. 2+ waves in arrhythmogenic Purkinje cells that survive in infarcted canine heart. Heart Rhythm 1 (2004) 218-226
167. 2+ diffusion from cytosol to nucleus in contracting adult rat cardiac myocytes with an ultra-fast confocal imaging system. Cell Calcium 25 (1999) 199-208
168. 2+ transport proteins in a rat heart. Mol Cell Biochem 301 (2007) 219-226
169. 3-I receptor mRNA expression in patients with atrial fibrillation. Chin Med J (Engl) 115 (2002) 664-667
170. 2+ signaling in a chronic dog model of atrial fibrillation. Cardiology 107 (2007) 269-276
171. Ehrlich J.R., Hohnloser S.H., and Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 27 (2006) 512-518
172. 3 release. Circulation 91 (1995) 2712-2716
173. Jacobsen A.N., Du X.J., Lambert K.A., Dart A.M., and Woodcock E.A. Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate. Circulation 93 (1996) 23-26
174. 3 generation. J Mol Cell Cardiol 32 (2000) 1851-1858
175. 2+ exchanger. J Mol Cell Cardiol 33 (2001) 1861-1869
176. Anderson K.E., Dart A.M., and Woodcock E.A. Inositol phosphate release and metabolism during myocardial ischemia and reperfusion in rat heart. Circ Res 76 (1995) 261-268
177. 3 during myocardial ischemia and its relationship to the development of arrhythmias. J Mol Cell Cardiol 28 (1996) 2129-2138
178. Mohler P.J., Davis J.Q., Davis L.H., Hoffman J.A., Michaely P., and Bennett V. Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B. J Biol Chem 279 (2004) 12980-12987
179. 3 receptor in a cardiac T-tubule/SR microdomain. PLoS Biol 3:e423 (2005) 2158-2167
180. Mohler P.J., Splawski I., Napolitano C., Bottelli G., Sharpe L., Timothy K., et al. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A 101 (2004) 9137-9142
181. 2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283 (2002) H1398-H1408
182. Lacombe V.A., Viatchenko-Karpinski S., Terentyev D., Sridhar A., Emani S., Bonagura J.D., et al. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am J Physiol Regul Integr Comp Physiol 293 (2007) R1787-R1797
183. 2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes 54 (2005) 2375-2381
184. Guner S., Arioglu E., Tay A., Tasdelen A., Aslamaci S., Bidasee K.R., et al. Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage. Mol Cell Biochem 263 (2004) 143-150
185. Zhou B.Q., Hu S.J., and Wang G.B. The analysis of ultrastructure and gene expression of sarco/endoplasmic reticulum calcium handling proteins in alloxan-induced diabetic rat myocardium. Acta Cardiol 61 (2006) 21-27
186. Xiang H., and McNeill J.H. Alpha 1-adrenoceptor-mediated phosphoinositide breakdown and inotropic responses in diabetic hearts. Am J Physiol 260 (1991) H557-H562
187. Tanaka Y., Kashiwagi A., Saeki Y., and Shigeta Y. Abnormalities in cardiac alpha 1-adrenoceptor and its signal transduction in streptozocin-induced diabetic rats. Am J Physiol 263 (1992) E425-E429
188. Tappia P.S., Asemu G., Aroutiounova N., and Dhalla N.S. Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy. Mol Cell Biochem 261 (2004) 193-199
189. 2+ release in skinned rat heart muscle. Am J Physiol 260 (1991) H1612-H1618
190. Rowley K.G., Tung L.H., Hodsman G.P., Howes L.G., Jarrott B., Beart P.M., et al. Altered alpha 1-adrenoceptor-mediated responses in atria of rats with chronic left ventricular infarction. J Cardiovasc Pharmacol 17 (1991) 474-479
191. Kawaguchi H., Sano H., Iizuka K., Okada H., Kudo T., Kageyama K., et al. Phosphatidylinositol metabolism in hypertrophic rat heart. Circ Res 72 (1993) 966-972
192. Kawaguchi H., Sano H., Okada H., Iizuka K., Okamoto H., Kudo T., et al. Increased calcium release from sarcoplasmic reticulum stimulated by inositol trisphosphate in spontaneously hypertensive rat heart cells. Mol Cell Biochem 119 (1993) 51-57
193. Dent M.R., Dhalla N.S., and Tappia P.S. Phospholipase C gene expression, protein content, and activities in cardiac hypertrophy and heart failure due to volume overload. Am J Physiol Heart Circ Physiol 287 (2004) H719-H727
194. Mende U., Kagen A., Meister M., and Neer E.J. Signal transduction in atria and ventricles of mice with transient cardiac expression of activated G protein alpha(q). Circ Res 85 (1999) 1085-1091
195. Berridge M.J. Cardiac calcium signalling. Biochem Soc Trans 31 (2003) 930-933
196. Bristow M.R., Minobe W., Rasmussen R., Hershberger R.E., and Hoffman B.B. Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther 247 (1988) 1039-1045
197. Regitz-Zagrosek V., Fielitz J., and Fleck E. Myocardial angiotensin receptors in human hearts. Basic Res Cardiol 93 Suppl 2 (1998) 37-42
198. Pieske B., Beyermann B., Breu V., Loffler B.M., Schlotthauer K., Maier L.S., et al. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99 (1999) 1802-1809
199. Zolk O., Quattek J., Sitzler G., Schrader T., Nickenig G., Schnabel P., et al. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 99 (1999) 2118-2123
200. Tappia P.S., Liu S.Y., Shatadal S., Takeda N., Dhalla N.S., and Panagia V. Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril. Am J Physiol 277 (1999) H40-H49
201. Ziegelhoffer A., Tappia P.S., Mesaeli N., Sahi N., Dhalla N.S., and Panagia V. Low level of sarcolemmal phosphatidylinositol 4,5-bisphosphate in cardiomyopathic hamster (UM-X7.1) heart. Cardiovasc Res 49 (2001) 118-126
202. 2+ leak in heart failure. Circ Res 97 (2005) 1314-1322
203. Kijima Y., Saito A., Jetton T.L., Magnuson M.A., and Fleischer S. Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes. J Biol Chem 268 (1993) 3499-3506
204. 2+-release channels of rat cardiac myocytes. J Mol Cell Cardiol 29 (1997) 1023-1036
205. 3 receptors in the rat heart. Biochim Biophys Acta 1763 (2006) 18-24